136 related articles for article (PubMed ID: 20510107)
1. [Expression of WT1 gene in CD34(+)CD38(-)CD123(+) AML stem cells and its significance analysis.].
Xu J; Wang HW; Yang T; Tan YH; Zhang L
Zhonghua Xue Ye Xue Za Zhi; 2010 Mar; 31(3):172-5. PubMed ID: 20510107
[TBL] [Abstract][Full Text] [Related]
2. Immunoprofiling of leukemic stem cells CD34+/CD38-/CD123+ delineate FLT3/ITD-positive clones.
Al-Mawali A; Gillis D; Lewis I
J Hematol Oncol; 2016 Jul; 9(1):61. PubMed ID: 27465508
[TBL] [Abstract][Full Text] [Related]
3. [WT1 gene expression and its isoform ratio in different cell subsets of normal human bone marrow].
Xu J; Wang HW; Li XH; Zhu L; Zhang L; Zhang F; Tan YH; Yang T
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):603-6. PubMed ID: 17605875
[TBL] [Abstract][Full Text] [Related]
4. Survival outcomes of CD34
Zahran AM; Aly SS; Rayan A; El-Badawy O; Fattah MA; Ali AM; ElBadre HM; Hetta HF
Oncotarget; 2018 Sep; 9(75):34056-34065. PubMed ID: 30344921
[TBL] [Abstract][Full Text] [Related]
5. Determination of P-glycoprotein, MDR-related protein 1, breast cancer resistance protein, and lung-resistance protein expression in leukemic stem cells of acute myeloid leukemia.
de Figueiredo-Pontes LL; Pintão MC; Oliveira LC; Dalmazzo LF; Jácomo RH; Garcia AB; Falcão RP; Rego EM
Cytometry B Clin Cytom; 2008 May; 74(3):163-8. PubMed ID: 18200595
[TBL] [Abstract][Full Text] [Related]
6. Tracing Leukemia Stem Cells and Their Influence on Clinical Course of Adult Acute Myeloid Leukemia.
Kandeel EZ; El Sharkawy N; Hanafi M; Samra M; Kamel A
Clin Lymphoma Myeloma Leuk; 2020 Jun; 20(6):383-393. PubMed ID: 32201129
[TBL] [Abstract][Full Text] [Related]
7. Enrichment of N-Cadherin and Tie2-bearing CD34+/CD38-/CD123+ leukemic stem cells by chemotherapy-resistance.
Zhi L; Wang M; Rao Q; Yu F; Mi Y; Wang J
Cancer Lett; 2010 Oct; 296(1):65-73. PubMed ID: 20444543
[TBL] [Abstract][Full Text] [Related]
8. Acquired expression of osteopontin selectively promotes enrichment of leukemia stem cells through AKT/mTOR/PTEN/β-catenin pathways in AML cells.
Mohammadi S; Ghaffari SH; Shaiegan M; Zarif MN; Nikbakht M; Akbari Birgani S; Alimoghadam K; Ghavamzadeh A
Life Sci; 2016 May; 152():190-8. PubMed ID: 27063991
[TBL] [Abstract][Full Text] [Related]
9. Delineation of target expression profiles in CD34+/CD38- and CD34+/CD38+ stem and progenitor cells in AML and CML.
Herrmann H; Sadovnik I; Eisenwort G; Rülicke T; Blatt K; Herndlhofer S; Willmann M; Stefanzl G; Baumgartner S; Greiner G; Schulenburg A; Mueller N; Rabitsch W; Bilban M; Hoermann G; Streubel B; Vallera DA; Sperr WR; Valent P
Blood Adv; 2020 Oct; 4(20):5118-5132. PubMed ID: 33085758
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometric quantification and immunophenotyping of leukemic stem cells in acute myeloid leukemia.
Hwang K; Park CJ; Jang S; Chi HS; Kim DY; Lee JH; Lee JH; Lee KH; Im HJ; Seo JJ
Ann Hematol; 2012 Oct; 91(10):1541-6. PubMed ID: 22669506
[TBL] [Abstract][Full Text] [Related]
11. Leukemia Stem Cell Frequency at Diagnosis Correlates With Measurable/Minimal Residual Disease and Impacts Survival in Adult Acute Myeloid Leukemia.
Kamel AM; Elsharkawy NM; Kandeel EZ; Hanafi M; Samra M; Osman RA
Front Oncol; 2022; 12():867684. PubMed ID: 35530356
[TBL] [Abstract][Full Text] [Related]
12. Impact of Leukemia Stem Cells Phenotype Expression on Response to Induction Therapy in Acute Myeloid Leukemia Patients.
Almohsen F; Al-Mudallal SS
Cardiovasc Hematol Disord Drug Targets; 2020; 20(2):145-151. PubMed ID: 31438833
[TBL] [Abstract][Full Text] [Related]
13. [Prognostic Significance of the Percentage of Blasts with CD34
Xiang LL; Qiu GQ; Xie XB; Cen JN; Hu SY; Gu WY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):61-65. PubMed ID: 28245376
[TBL] [Abstract][Full Text] [Related]
14. [Expression of 5 genes in CD7 positive acute myeloid leukemia stem/progenitor cells from bone marrow].
Wu HH; Cao H; Wang YZ; Wang DX; Lin HR; Qin YZ; Chang Y; Hao L; Li LD; Li JL; Ruan GR; Huang XJ; Liu YR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Apr; 17(2):298-303. PubMed ID: 19379555
[TBL] [Abstract][Full Text] [Related]
15. [Characteristic and prognostic significance of leukemia stem cells associated antigens expressions in t (8;21) acute myeloid leukemia].
Dao FT; Yang L; Wang YZ; Chang Y; Jiang Q; Jiang H; Liu YR; Huang XJ; Qin YZ
Zhonghua Xue Ye Xue Za Zhi; 2019 Oct; 40(10):831-836. PubMed ID: 31775482
[No Abstract] [Full Text] [Related]
16. [The immunophenotypic analysis of CD7+ and (or) CD56+ acute myeloid leukemic stem cells and its applications in minimal residual disease detection].
Cao H; Wang YZ; Wu HH; Chang Y; Hao L; Chen SS; Huang XJ; Lu DP; Liu YR
Zhonghua Xue Ye Xue Za Zhi; 2008 Jan; 29(1):23-8. PubMed ID: 18512311
[TBL] [Abstract][Full Text] [Related]
17. Phenotyping and Target Expression Profiling of CD34
Blatt K; Menzl I; Eisenwort G; Cerny-Reiterer S; Herrmann H; Herndlhofer S; Stefanzl G; Sadovnik I; Berger D; Keller A; Hauswirth A; Hoermann G; Willmann M; Rülicke T; Sill H; Sperr WR; Mannhalter C; Melo JV; Jäger U; Sexl V; Valent P
Neoplasia; 2018 Jun; 20(6):632-642. PubMed ID: 29772458
[TBL] [Abstract][Full Text] [Related]
18. CD34+CD38-CD123+ Cells Are Present in Virtually All Acute Myeloid Leukaemia Blasts: A Promising Single Unique Phenotype for Minimal Residual Disease Detection.
Al-Mawali A; Pinto AD; Al-Zadjali S
Acta Haematol; 2017; 138(3):175-181. PubMed ID: 29065396
[TBL] [Abstract][Full Text] [Related]
19. High expression of WT1 gene in acute myeloid leukemias with more predominant WT1+17AA isoforms at relapse.
Gu W; Hu S; Chen Z; Qiu G; Cen J; He B; He J; Wu W
Leuk Res; 2010 Jan; 34(1):46-9. PubMed ID: 19414192
[TBL] [Abstract][Full Text] [Related]
20. Attenuation of microRNA-126 expression that drives CD34+38- stem/progenitor cells in acute myeloid leukemia leads to tumor eradication.
de Leeuw DC; Denkers F; Olthof MC; Rutten AP; Pouwels W; Schuurhuis GJ; Ossenkoppele GJ; Smit L
Cancer Res; 2014 Apr; 74(7):2094-105. PubMed ID: 24477595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]